Both in Pharmaceuticals
Maravai LifeSciences Holdings vs Amphastar Pharmaceuticals
Over the past year MRVI returned +170.3% and AMPH returned −0.9%; their daily moves had a correlation of 0.01.
MRVI +170.3% AMPH −0.9%Growth of $1, one year, split-adjusted
| Metric | MRVI | AMPH |
|---|---|---|
| Price | $7.65 | $26.68 |
| Market cap | $1.14B | $1.13B |
| Today | +0.26% | −2.59% |
| 1 month | −0.4% | +21.2% |
| 6 months | +165.6% | +38.8% |
| Year to date | +135.4% | −0.4% |
| 1 year | +171.3% | −0.6% |
| Revenue growth (YoY) | +8.5% | +5.4% |
| Gross margin | 40.1% | 50.8% |
| Net margin | −24.1% | 16.5% |
| P/E (TTM) | — | 14.4× |
| Price / sales | 5.5× | 1.6× |
| Net cash | -$106.6M | -$321.9M |
| Dividend yield | — | — |
| Volatility (60d) | 73.2% | 35.4% |
| Short % of float | 9.9% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).